Progress in xenotransplantation: overcoming immune barriers

Area of Science:

• Transplantation immunology
• Genetics
• Surgical innovation

Background:

• The critical shortage of human donor organs leads to thousands of patient deaths annually.
• Advances in xenotransplantation, particularly using genetically modified pig organs, show promise for alleviating this shortage.
• Recent pig-to-human transplants and experiments in deceased recipients provide encouraging preliminary data.

Purpose of the Study:

• To explore the potential of xenotransplantation to address the organ shortage.
• To highlight the role of genetic modification in improving xenograft compatibility.
• To identify the challenges and desirable outcomes for clinical xenotransplantation.

Main Methods:

• Utilizing genetic modification techniques like CRISPR-Cas9 to alter pig organs for enhanced human compatibility.
• Performing xenotransplantation experiments, including pig-to-human heart and kidney transplants.
• Investigating the complex immune responses, including innate immunity, that affect xenograft survival.

Main Results:

• Genetically modified pig organs demonstrate improved physiological compatibility with humans, reducing rejection potential.
• Long-term graft survival has been achieved in non-human primates, indicating significant progress.
• Encouraging initial data from pig organ transplantation in human recipients has been reported.

Conclusions:

• Xenotransplantation holds significant potential to overcome the global organ deficit.
• Further research is needed to induce immune tolerance, balancing rejection prevention with infection protection.
• Overcoming innate and adaptive immune responses is crucial for the clinical success of xenotransplantation.